Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can ...
The Federal Reserve's favorite inflation gauge is due out this morning. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...
Palantir Technologies (NASDAQ: PLTR) stock was one of the top performers on the stock market in 2024, jumping 340% in 2024. The defense tech stock was fueled by a ramp in revenue growth and operating ...
Stock futures held onto earlier gains after the Federal Reserve’s preferred inflation gauge matched expectations. Dow futures were up 0.3%. S&P 500 futures were up 0.4%. Nasdaq 100 futures were up 0.7 ...
Some results have been hidden because they may be inaccessible to you